Home › Macular Edema › Indiana › Carmel
Macular Edema clinical trials in Carmel, IN
5 studies for Macular Edema are looking for participants at sites in and around Carmel (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
- Midwest Eye Institute ( Site 0113), Carmel
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
RecruitingPhase 3
- Associated Vitreoretinal and Uveitis Consultants ( Site 0099), Carmel
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
RecruitingPhase 2
- Associated Vitreoretinal and Uveitis Consultants, Carmel
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
RecruitingPhase 3
- Associated Vitreoretinal and Uveitis Consultants LLC, Carmel
- Midwest Eye Institute, Carmel
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
RecruitingPhase 3
- Associated Vitreoretinal and Uveitis Consultants LLC, Carmel
- Midwest Eye Institute, Carmel
Macular Edema trials in other cities
- Hagerstown, MD5 studies
- San Antonio, TX5 studies
- Sacramento, CA4 studies
- The Woodlands, TX4 studies
- Raleigh, NC4 studies
- Austin, TX4 studies
- Phoenix, AZ4 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Plano, TX3 studies
- Columbia, SC3 studies
- Glendale, CA3 studies
Other studies in Carmel
- Macular Degeneration7 studies
- Geographic Atrophy4 studies
- Prostate Cancer3 studies
- Coronary Artery Disease3 studies
- Diabetic Eye Problems3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.